Copeland Closes Dickson Deal to Expand Cold Chain Monitoring

Copeland announced that it has completed its acquisition of Dickson, a Chicago-based provider of environmental monitoring and compliance technology for life sciences and healthcare, combining Dickson's cloud-based monitoring platform with Copeland's controls and enterprise software across the cold chain from pharmaceutical manufacturing through distribution and patient care.¹

In an announcement, Copeland said increasing regulatory demands across the pharmaceutical and life sciences cold chain require continuous visibility from production through final delivery.¹ That visibility carries growing financial weight, as temperature excursions cost pharma an estimated $35 billion a year while biologics, GLP-1s and cell and gene therapies raise cold chain stakes.

"The acquisition of Dickson further strengthens our ability to serve customers across every stage of the healthcare and life sciences cold chain, from pharmaceutical manufacturing through distribution and patient care," said Ross B. Shuster, CEO of Copeland, in a press release.¹ "We are pleased to welcome the Dickson team, with their expertise and capabilities, to Copeland."

Rick Weiler, president and CEO of Dickson, pointed to the regulatory demands of the company's customer base. "Our customers operate in highly regulated environments where precision, compliance and visibility are essential," Weiler said.¹ "By joining Copeland, we are bringing together complementary technologies and expertise that support the monitoring and protection of temperature-sensitive products across increasingly complex supply chains."

What Does the Combined Portfolio Cover?

According to Copeland, the pairing of Dickson's cloud-native monitoring platform with its own controls, monitoring and enterprise software is intended to create a more connected and compliant cold chain.¹ The company outlined three areas the combined offering will address:

• Temperature monitoring: Solutions supporting biotechnology manufacturing, pharmaceutical distribution, healthcare, retail pharmacy and medical device environments.
• End-to-end visibility: Integrated environmental monitoring, software and compliance capabilities covering conditions from production and storage through transportation and delivery.
• Risk and product loss: Data-driven insights designed to identify and address issues early, protecting pharmaceutical and other temperature-sensitive products throughout the supply chain.

Why Is Real-Time Monitoring Drawing Investment?

The deal lands in a growing segment. According to a market report, the global market for real-time temperature and location monitoring platforms in the cold chain was estimated at $4.3 billion in 2025 and is expected to grow at an 11.9% CAGR from 2026 to 2036 as logistics teams move away from after-the-fact compliance records toward real-time tracking platforms, which let them intervene before a temperature deviation crosses a critical threshold and puts a shipment at risk.²

The acquisition also reflects a broader move toward integrated monitoring in the pharmaceutical industry. In a previous interview with Pharmaceutical Commerce, Anthony "TJ" Rizzo, chief commercial officer at Cold Chain Technologies, noted integrated digital platforms can replace disconnected monitoring and reporting across multiple partners and handoffs, and described where he expects the sector to head over the next five years.³

"We’re in the era right now of where this technology we've been talking about, whether it be control towers or real-time monitoring and automation and AI, is really going to continue to just explode over the next five years in particular,” Rizzo said.³

“Cold chains will continue to move toward integrated thermal assurance ecosystems rather than standalone solutions," he added.³

With Dickson, Copeland brings a monitoring and compliance platform together with its compression and controls portfolio.

References

1. Copeland. "Copeland Completes Acquisition of Dickson, Advancing Cold Chain Intelligence for Healthcare and Life Sciences." Business Wire. Sept. 23, 2026. https://www.businesswire.com/news/home/20260923247992/en/Copeland-Completes-Acquisition-of-Dickson-Advancing-Cold-Chain-Intelligence-for-Healthcare-and-Life-Sciences
2. Future Market Insights. Real-Time Temperature and Location Monitoring Platforms for Cold Chain Market: Global Forecast 2026 to 2036. Accessed Sept. 24, 2026. https://www.futuremarketinsights.com/reports/real-time-temperature-and-location-monitoring-platforms-for-cold-chain-market
3. Appezzato S, Rizzo A. "How Automation and Real-Time Monitoring Improve Cold Chain Resilience." Pharmaceutical Commerce. April 22, 2026. https://www.pharmaceuticalcommerce.com/view/how-automation-and-real-time-monitoring-improve-cold-chain-resilience